{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:39:06Z","timestamp":1792118346675,"version":"4.4.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ecl.2021.11.016","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T15:58:34Z","timestamp":1644335914000},"page":"1-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Epidemiology of Male Hypogonadism"],"prefix":"10.1016","volume":"51","author":[{"given":"Arthi","family":"Thirumalai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley D.","family":"Anawalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2021.11.016_bib1","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1210\/jc.2012-2400","article-title":"Approach to male infertility and induction of spermatogenesis","volume":"98","author":"Anawalt","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/humupd\/dmx021","article-title":"The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities","volume":"23","author":"Barratt","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2021.11.016_bib3","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib4","first-page":"423","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ecl.2021.11.016_bib5","first-page":"812","article-title":"Testosterone deficiency: a review and comparison of current guidelines","volume":"16","author":"Kwong","year":"2019","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.ecl.2021.11.016_bib6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jc.2016-2935","article-title":"Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe","volume":"102","author":"Travison","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/cen.14075","article-title":"Male sickle cell patients, compensated transpubertal hypogonadism and normal final growth","volume":"91","author":"Martins","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/cen.14428","article-title":"Compensated hypogonadism in men with sickle cell disease","volume":"94","author":"Ribeiro","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/andr.12370","article-title":"Reproductive endocrine issues in men with sickle cell anemia","volume":"5","author":"Huang","year":"2017","journal-title":"Andrology"},{"key":"10.1016\/j.ecl.2021.11.016_bib10","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/515S2a","article-title":"Epidemiology: a moving target","volume":"515","author":"Pleasants","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ecl.2021.11.016_bib11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging","volume":"86","author":"Harman","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib12","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1210\/jc.2010-3012","article-title":"Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts","volume":"96","author":"Bhasin","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2021.11.016_bib14","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2011-2513","article-title":"Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)","volume":"97","author":"Tajar","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/EJE-15-0380","article-title":"Age-specific population centiles for androgen status in men","volume":"173","author":"Handelsman","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.11.016_bib16","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2007-1245","article-title":"Prevalence of symptomatic androgen deficiency in men","volume":"92","author":"Araujo","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib17","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1210\/jc.2003-031719","article-title":"Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study","volume":"89","author":"Araujo","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/aja.aja_59_20","article-title":"Prevalence of late-onset hypogonadism among middle-aged and elderly males in China: results from a national survey","volume":"23","author":"Liu","year":"2021","journal-title":"Asian J Androl"},{"key":"10.1016\/j.ecl.2021.11.016_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Nguengang Wakap","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ecl.2021.11.016_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5694\/j.1326-5377.2011.tb04141.x","article-title":"The prevalence and diagnosis rates of Klinefelter syndrome: an Australian comparison","volume":"194","author":"Herlihy","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.ecl.2021.11.016_bib21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/jc.2002-021491","article-title":"Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study","volume":"88","author":"Bojesen","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13023-018-0976-2","article-title":"Changes in the cohort composition of Turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: a nationwide cohort study","volume":"14","author":"Berglund","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ecl.2021.11.016_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2017-00212","article-title":"Klinefelter syndrome: integrating genetics, neuropsychology, and endocrinology","volume":"39","author":"Gravholt","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2021.11.016_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/jc.2012-2382","article-title":"Clinical review: Klinefelter syndrome--a clinical update","volume":"98","author":"Groth","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib25","doi-asserted-by":"crossref","first-page":"e23292","DOI":"10.1371\/journal.pone.0023292","article-title":"Clinical, biological and genetic analysis of anorchia in 26 boys","volume":"6","author":"Brauner","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ecl.2021.11.016_bib26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","article-title":"Current estimate of down syndrome population prevalence in the United States","volume":"163","author":"Presson","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ecl.2021.11.016_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1468-3148.2010.00593.x","article-title":"Assessment of prevalence of persons with down syndrome: a theory-based demographic model","volume":"24","author":"De Graaf","year":"2011","journal-title":"J\u00a0Appl Res Intellect Disabil"},{"key":"10.1016\/j.ecl.2021.11.016_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0301-2115(01)00478-X","article-title":"Bone mass, gonadal function and biochemical assessment in young men with trisomy 21","volume":"100","author":"Sakadamis","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ecl.2021.11.016_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10815-019-01457-2","article-title":"Down syndrome and infertility: what support should we provide?","volume":"36","author":"Parizot","year":"2019","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ecl.2021.11.016_bib30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00198-012-2109-4","article-title":"Low bone turnover and low bone density in a cohort of adults with down syndrome","volume":"24","author":"McKelvey","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2021.11.016_bib31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ajmg.1320270223","article-title":"Gonadal function in patients with down syndrome","volume":"27","author":"Hsiang","year":"1987","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ecl.2021.11.016_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MED.0000000000000382","article-title":"Endocrine manifestations of down syndrome","volume":"25","author":"Whooten","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ecl.2021.11.016_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2021.11.016_bib34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan syndrome: clinical features, diagnosis, and management guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ecl.2021.11.016_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-11-0092","article-title":"Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: a longitudinal study","volume":"165","author":"Ankarberg-Lindgren","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.11.016_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-18-0582","article-title":"Noonan syndrome males display Sertoli cell-specific primary testicular insufficiency","volume":"179","author":"Moniez","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.11.016_bib37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ecl.2021.11.016_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/CND.0b013e318176eb55","article-title":"Hypogonadism is common in men with myopathies","volume":"9","author":"Al-Harbi","year":"2008","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"key":"10.1016\/j.ecl.2021.11.016_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF03350681","article-title":"Hypothalamic-pituitary-testicular function in 70 patients with myotonic dystrophy","volume":"13","author":"Vazquez","year":"1990","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ecl.2021.11.016_bib40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2021.11.016_bib41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40618-017-0740-9","article-title":"Polyglandular autoimmune syndromes","volume":"41","author":"Kahaly","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ecl.2021.11.016_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/cei.12303","article-title":"Gonadal function in males with autoimmune Addison's disease and autoantibodies to steroidogenic enzymes","volume":"176","author":"Dalla Costa","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ecl.2021.11.016_bib43","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1210\/er.2019-00049","article-title":"Management of 46,XY differences\/disorders of sex development (DSD) throughout life","volume":"40","author":"Wisniewski","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2021.11.016_bib44","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.3390\/ijerph18094796","article-title":"Clinical spectrum associated with Wolfram syndrome type 1 and type 2: a review on genotype-phenotype correlations","volume":"18","author":"Delvecchio","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ecl.2021.11.016_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ecl.2021.11.016_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med"},{"issue":"6 Suppl4","key":"10.1016\/j.ecl.2021.11.016_bib47","first-page":"S67","article-title":"Scrotal trauma: a case report and review of the literature","volume":"13","author":"Randhawa","year":"2019","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.ecl.2021.11.016_bib48","series-title":"EAU guidelines on urological trauma","author":"Kitrey","year":"2016"},{"key":"10.1016\/j.ecl.2021.11.016_bib49","first-page":"51","article-title":"National analysis of testicular and scrotal trauma in the USA","volume":"10","author":"Grigorian","year":"2018","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.ecl.2021.11.016_bib50","first-page":"2009","article-title":"Pediatric testicular torsion epidemiology using a national database: incidence, risk of orchiectomy and possible measures toward improving the quality of care","volume":"186","author":"Zhao","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ecl.2021.11.016_bib51","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1111\/apa.12275","article-title":"The incidence rate and characteristics in patients with testicular torsion: a nationwide, population-based study","volume":"102","author":"Huang","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ecl.2021.11.016_bib52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5534\/wjmh.190037","article-title":"The impact of testicular torsion on testicular function","volume":"38","author":"Jacobsen","year":"2020","journal-title":"World J Mens Health"},{"key":"10.1016\/j.ecl.2021.11.016_bib53","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1464-410X.2009.09148.x","article-title":"The increasing incidence of mumps orchitis: a comprehensive review","volume":"105","author":"Davis","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.ecl.2021.11.016_bib54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MD.0b013e3181d63191","article-title":"Mumps orchitis in the post-vaccine era (1967\u20132009): a single-center series of 67 patients and review of clinical outcome and trends","volume":"89","author":"Ternavasio-de la Vega","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.ecl.2021.11.016_bib55","doi-asserted-by":"crossref","first-page":"dgz184","DOI":"10.1210\/clinem\/dgz184","article-title":"The molecular basis of congenital hypopituitarism and related disorders","volume":"105","author":"Gregory","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000338706","article-title":"Genetic overlap between holoprosencephaly and Kallmann syndrome","volume":"3","author":"Vaaralahti","year":"2012","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.ecl.2021.11.016_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00439-020-02147-1","article-title":"Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease","volume":"140","author":"Cangiano","year":"2021","journal-title":"Hum Genet"},{"key":"10.1016\/j.ecl.2021.11.016_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1172-6-41","article-title":"Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland","volume":"6","author":"Laitinen","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ecl.2021.11.016_bib59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1530\/EJE-10-0083","article-title":"Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships","volume":"162","author":"Brioude","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.11.016_bib60","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1210\/er.2016-1101","article-title":"Genetics of combined pituitary hormone deficiency: roadmap into the genome era","volume":"37","author":"Fang","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2021.11.016_bib61","series-title":"Endotext [Internet]","article-title":"Familial or sporadic adrenal hypoplasia syndromes","author":"Kyritsi","year":"2018"},{"key":"10.1016\/j.ecl.2021.11.016_bib62","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.c.31593","article-title":"Guidelines in CHARGE syndrome and the missing link: Cranial imaging","volume":"175","author":"de Geus","year":"2017","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ecl.2021.11.016_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejhg.2012.115","article-title":"Bardet-Biedl syndrome","volume":"21","author":"Forsythe","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ecl.2021.11.016_bib64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.15252\/embr.201744632","article-title":"WDR11-mediated Hedgehog signalling defects underlie a new ciliopathy related to Kallmann syndrome","volume":"19","author":"Kim","year":"2018","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ecl.2021.11.016_bib65","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJMoa071999","article-title":"Luteinizing hormone beta mutation and hypogonadism in men and women","volume":"357","author":"Lofrano-Porto","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2021.11.016_bib66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","article-title":"The epidemiology of pituitary adenomas","volume":"49","author":"Daly","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2021.11.016_bib67","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib68","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study","volume":"173","author":"Sigurdsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.11.016_bib69","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1590\/2359-3997000000195","article-title":"Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a health management organization in Buenos Aires, Argentina","volume":"60","author":"Day","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib70","doi-asserted-by":"crossref","first-page":"bvaa021","DOI":"10.1210\/jendso\/bvaa021","article-title":"Presenting features in 269 patients with clinically nonfunctioning pituitary adenomas enrolled in a prospective study","volume":"4","author":"Freda","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ecl.2021.11.016_bib71","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000503256","article-title":"Clinically nonfunctioning pituitary incidentalomas: characteristics and natural history","volume":"110","author":"Tresoldi","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ecl.2021.11.016_bib72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11060-010-0302-x","article-title":"A\u00a0prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome","volume":"102","author":"Chen","year":"2011","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib73","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1530\/EC-18-0065","article-title":"A\u00a0comparative, population-based analysis of pituitary incidentalomas vs clinically manifesting sellar masses","volume":"7","author":"Vaninetti","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ecl.2021.11.016_bib74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.2011.04235.x","article-title":"Rathke's cleft cysts","volume":"76","author":"Trifanescu","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib75","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1017\/cjn.2016.290","article-title":"The international incidence of traumatic brain injury: a systematic review and meta-analysis","volume":"43","author":"Nguyen","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.ecl.2021.11.016_bib76","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/CCM.0000000000000046","article-title":"Clinical outcomes, predictors, and prevalence of anterior pituitary disorders following traumatic brain injury: a systematic review","volume":"42","author":"Lauzier","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ecl.2021.11.016_bib77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/bs.pmbts.2015.10.010","article-title":"GH and pituitary hormone alterations after traumatic brain injury","volume":"138","author":"Karaca","year":"2016","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.ecl.2021.11.016_bib78","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3109\/02699052.2010.506863","article-title":"Anterior pituitary dysfunction in moderate- to-severe chronic traumatic brain injury patients and the influence on functional outcome","volume":"24","author":"Park","year":"2010","journal-title":"Brain Inj"},{"key":"10.1016\/j.ecl.2021.11.016_bib79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11102-019-00956-w","article-title":"Clinical picture and the treatment of TBI-induced hypopituitarism","volume":"22","author":"Caputo","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2021.11.016_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrendo.2017.103","article-title":"Chronic endocrine consequences of traumatic brain injury - what is the evidence?","volume":"14","author":"Klose","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ecl.2021.11.016_bib81","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1089\/neu.2015.4109","article-title":"Neuroendocrine disturbances one to five or more years after traumatic brain injury and aneurysmal subarachnoid hemorrhage: data from the German database on hypopituitarism","volume":"33","author":"Krewer","year":"2016","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ecl.2021.11.016_bib82","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1227\/NEU.0000000000001157","article-title":"Pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"79","author":"Can","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ecl.2021.11.016_bib83","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamaneurol.2019.0006","article-title":"Subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis","volume":"76","author":"Etminan","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ecl.2021.11.016_bib84","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ane.12980","article-title":"Prospective study: long-term outcome at 12-15 years after aneurysmal subarachnoid hemorrhage","volume":"138","author":"Rackauskaite","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ecl.2021.11.016_bib85","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary apoplexy","volume":"36","author":"Briet","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2021.11.016_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","article-title":"UK guidelines for the management of pituitary apoplexy","volume":"74","author":"Rajasekaran","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib87","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11102-018-0870-x","article-title":"Apoplexy in nonfunctioning pituitary adenomas","volume":"21","author":"Wildemberg","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2021.11.016_bib88","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1530\/EJE-17-0505","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: Primary empty sella: a comprehensive review","volume":"177","author":"Chiloiro","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.11.016_bib89","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11102-012-0416-6","article-title":"Primary empty sella (PES): a review of 175 cases","volume":"16","author":"Guitelman","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2021.11.016_bib90","first-page":"99","article-title":"Primary empty sella syndrome and the prevalence of hormonal dysregulation","volume":"115","author":"Auer","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.ecl.2021.11.016_bib91","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1210\/jc.2004-0980","article-title":"Hypogonadism in hereditary hemochromatosis","volume":"90","author":"McDermott","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib92","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG clinical guideline: hereditary hemochromatosis","volume":"114","author":"Kowdley","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ecl.2021.11.016_bib93","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s40618-016-0451-7","article-title":"Endocrine dysfunction in hereditary hemochromatosis","volume":"39","author":"Pelusi","year":"2016","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2-S","key":"10.1016\/j.ecl.2021.11.016_bib94","first-page":"6","article-title":"Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment","volume":"89","author":"De Sanctis","year":"2018","journal-title":"Acta Biomed"},{"key":"10.1016\/j.ecl.2021.11.016_bib95","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1445-5994.2011.02527.x","article-title":"Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias","volume":"41","author":"Ho","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.ecl.2021.11.016_bib96","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cen.13156","article-title":"The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS)","volume":"86","author":"Soto-Pedre","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib97","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/cen.12124","article-title":"Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?","volume":"79","author":"Karavitaki","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib98","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11102-014-0563-z","article-title":"Hypopituitarism patterns and prevalence among men with macroprolactinomas","volume":"18","author":"Tirosh","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2021.11.016_bib99","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11102-018-0898-y","article-title":"Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study","volume":"21","author":"Liu","year":"2018","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.ecl.2021.11.016_bib100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/jcem-45-3-488","article-title":"Reversible gonadotropin deficiency in male Cushing's disease","volume":"45","author":"Luton","year":"1977","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib101","first-page":"501","article-title":"Testicular activity in Cushing's disease","volume":"91","author":"McKenna","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.ecl.2021.11.016_bib102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ecl.2007.10.010","article-title":"Cushing's syndrome","volume":"37","author":"Pivonello","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2021.11.016_bib103","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1210\/clinem\/dgaa858","article-title":"The hypothalamic-pituitary-thyroid axis in Cushing syndrome before and after curative surgery","volume":"106","author":"Shekhar","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib104","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing's disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2021.11.016_bib105","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib106","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib107","first-page":"1224","article-title":"Global, regional and national burden of prostate cancer, 1990 to 2015: results from the Global Burden of Disease Study 2015","volume":"199","author":"Pishgar","year":"2018","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ecl.2021.11.016_bib108","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ecl.2021.11.016_bib109","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/pros.23967","article-title":"Optimizing the role of androgen deprivation therapy in advanced prostate cancer: challenges beyond the guidelines","volume":"80","author":"Shore","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.ecl.2021.11.016_bib110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jamaoncol.2020.6973","article-title":"Comparison of systemic treatments for metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis","volume":"7","author":"Wang","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib111","first-page":"14","article-title":"Advanced prostate cancer: AUA\/ASTRO\/SUO guideline PART I","volume":"205","author":"Lowrance","year":"2021","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ecl.2021.11.016_bib112","first-page":"22","article-title":"Advanced prostate cancer: AUA\/ASTRO\/SUO guideline PART II","volume":"205","author":"Lowrance","year":"2021","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ecl.2021.11.016_bib113","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/ijc.24870","article-title":"The effect of study arm on prostate cancer treatment in the large screening trial ERSPC","volume":"126","author":"Wolters","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ecl.2021.11.016_bib114","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2021.11.016_bib115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A\u00a016-yr follow-up of the European randomized study of screening for prostate cancer","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ecl.2021.11.016_bib116","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2021.11.016_bib117","article-title":"Synchronous bilateral testicular cancer with discordant histopathology occurring in a 20-year-old patient: a case report and review of the literature","author":"Symeonidis","year":"2021","journal-title":"Urologia"},{"key":"10.1016\/j.ecl.2021.11.016_bib118","doi-asserted-by":"crossref","first-page":"459","DOI":"10.6004\/jnccn.2018.7109","article-title":"Adverse health outcomes in relationship to hypogonadism after chemotherapy: a multicenter study of testicular cancer survivors","volume":"17","author":"Abu Zaid","year":"2019","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ecl.2021.11.016_bib119","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cen.13792","article-title":"Should survivors of childhood cancer or testicular cancer be screened for androgen deficiency?","volume":"89","author":"Rogol","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.urolonc.2021.02.028","article-title":"A\u00a025-year review of advances in testicular cancer: perspectives on evaluation, treatment, and future directions\/challenges","volume":"39","author":"Masterson","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib121","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6602677","article-title":"Fertility, gonadal and sexual function in survivors of testicular cancer","volume":"93","author":"Huddart","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ecl.2021.11.016_bib122","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.eururo.2007.05.012","article-title":"The quality of life and hormonal disturbances in testicular cancer survivors in cisplatin era","volume":"52","author":"Wiechno","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.ecl.2021.11.016_bib123","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/1097-0142(20010401)91:7<1297::AID-CNCR1132>3.0.CO;2-Z","article-title":"The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors","volume":"91","author":"Gerl","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2021.11.016_bib124","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/iju.13537","article-title":"High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors","volume":"25","author":"Kurobe","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.ecl.2021.11.016_bib125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/andr.12177","article-title":"Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysis","volume":"4","author":"Bandak","year":"2016","journal-title":"Andrology"},{"key":"10.1016\/j.ecl.2021.11.016_bib126","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an Endocrine Society clinical practice guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib127","doi-asserted-by":"crossref","first-page":"dgz132","DOI":"10.1210\/clinem\/dgz132","article-title":"Is chemotherapy implicated in the development of hypopituitarism in childhood cancer survivors?","volume":"105","author":"Seejore","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib128","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/cen.13534","article-title":"High risk of hypogonadism in young male cancer survivors","volume":"88","author":"Isaksson","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib129","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1210\/jc.2019-00834","article-title":"Hypothalamic-pituitary disorders in childhood cancer survivors: prevalence, risk factors and long-term health outcomes","volume":"104","author":"van Iersel","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2265.2008.03283.x","article-title":"Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL)","volume":"69","author":"Steffens","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib131","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1210\/er.2018-00092","article-title":"Long-term endocrine and metabolic consequences of cancer treatment: a systematic review","volume":"40","author":"Gebauer","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2021.11.016_bib132","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijrobp.2008.10.011","article-title":"Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer","volume":"74","author":"Yau","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ecl.2021.11.016_bib133","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2004.12.017","article-title":"Testicular dose and hormonal changes after radiotherapy of rectal cancer","volume":"75","author":"Hermann","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib134","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/neuonc\/nou283","article-title":"The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis","volume":"17","author":"de Robles","year":"2015","journal-title":"Neuro Oncol"},{"issue":"12 Suppl 2","key":"10.1016\/j.ecl.2021.11.016_bib135","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib136","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2021.11.016_bib137","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0039-1696724","article-title":"Factors associated with and temporal trends in the use of radiation therapy for the treatment of pituitary adenoma in the national cancer database","volume":"82","author":"Fathy","year":"2021","journal-title":"J\u00a0Neurol Surg B Skull Base"},{"key":"10.1016\/j.ecl.2021.11.016_bib138","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","article-title":"The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas","volume":"38","author":"Brada","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib139","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00066-007-1706-1","article-title":"Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome","volume":"183","author":"Langsenlehner","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ecl.2021.11.016_bib140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0035-1549309","article-title":"Clinical and radiologic outcome of gamma knife radiosurgery on nonfunctioning pituitary adenomas","volume":"76","author":"Bir","year":"2015","journal-title":"J\u00a0Neurol Surg B Skull Base"},{"key":"10.1016\/j.ecl.2021.11.016_bib141","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11102-018-0868-4","article-title":"Management of nonfunctioning pituitary tumors: radiotherapy","volume":"21","author":"Minniti","year":"2018","journal-title":"Pituitary"},{"issue":"Suppl1","key":"10.1016\/j.ecl.2021.11.016_bib142","first-page":"47","article-title":"Hypopituitarism after gamma knife surgery for postoperative nonfunctioning pituitary adenoma","volume":"129","author":"Oh","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.ecl.2021.11.016_bib143","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2008-2772","article-title":"Long-term results of stereotactic radiosurgery in secretory pituitary adenomas","volume":"94","author":"Castinetti","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib144","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/cen.12938","article-title":"Gamma knife radiosurgery in patients with persistent acromegaly or Cushing's disease: long-term risk of hypopituitarism","volume":"84","author":"Cohen-Inbar","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.wneu.2017.06.127","article-title":"Trends in management of intracranial meningiomas: analysis of 49,921 cases from modern cohort","volume":"106","author":"Agarwal","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ecl.2021.11.016_bib146","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1016\/j.prro.2019.01.009","article-title":"Hypopituitarism after cranial irradiation for meningiomas: a single-Institution experience","volume":"9","author":"Lamba","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib147","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1210\/jc.2005-1525","article-title":"Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults","volume":"90","author":"Agha","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.11.016_bib148","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib149","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/cen.12969","article-title":"Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours","volume":"84","author":"Kyriakakis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.11.016_bib150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/neuonc\/noz153","article-title":"EANO guideline on the diagnosis and treatment of vestibular schwannoma","volume":"22","author":"Goldbrunner","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib151","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.otc.2015.02.010","article-title":"Stereotactic radiosurgery in the management of vestibular schwannoma and glomus jugulare: indications, techniques, and results","volume":"48","author":"Jacob","year":"2015","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.ecl.2021.11.016_bib152","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10143-019-01103-6","article-title":"Stereotactic radiosurgery and radiotherapy for acoustic neuromas","volume":"43","author":"Kalogeridi","year":"2020","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.ecl.2021.11.016_bib153","first-page":"726","article-title":"Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010","volume":"19","author":"Zhang","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib154","first-page":"1","article-title":"Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study","volume":"3","author":"Habbous","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ecl.2021.11.016_bib155","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1186\/s12885-019-6431-5","article-title":"Are hypothalamic- pituitary (HP) axis deficiencies after whole brain radiotherapy (WBRT) of relevance for adult cancer patients? - a systematic review of the literature","volume":"19","author":"Mehta","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ecl.2021.11.016_bib156","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000486034","article-title":"Endocrine and metabolic disturbances in survivors of hematopoietic stem cell transplantation in childhood and adolescence","volume":"89","author":"Shalitin","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ecl.2021.11.016_bib157","first-page":"48","article-title":"Endocrine disorders in childhood cancer survivors treated with haemopoietic stem cell transplantation","volume":"1","author":"Wei","year":"2014","journal-title":"Children (Basel)"},{"key":"10.1016\/j.ecl.2021.11.016_bib158","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2018.0026","article-title":"NCCN guidelines insights: head and neck cancers, version 1.2018","volume":"16","author":"Colevas","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ecl.2021.11.016_bib159","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.radonc.2014.08.018","article-title":"Pituitary dysfunction in adult patients after cranial irradiation for head and nasopharyngeal tumours","volume":"113","author":"Appelman-Dijkstra","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ecl.2021.11.016_bib161","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1210\/jc.2018-01882","article-title":"Diagnosis and management of anabolic androgenic steroid use","volume":"104","author":"Anawalt","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921001183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921001183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:48:11Z","timestamp":1760176091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852921001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0889852921001183"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2021.11.016","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of Male Hypogonadism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2021.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}